Related Experiment Videos
Acyclic nucleoside/nucleotide analogues with an imidazole ring skeleton
1Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore 21250, USA.
Nucleosides, Nucleotides & Nucleic Acids
|September 14, 2001
Summary
Researchers synthesized novel acyclic nucleoside and phosphonate analogues with imidazole rings. The phosphonate analogue 9 demonstrated significant anti-measles virus activity, showing potential for antiviral drug development.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Virology
Background:
- Acyclic nucleoside and phosphonate analogues are crucial in antiviral drug discovery.
- Imidazole-containing compounds have shown promise in medicinal applications.
- Developing novel antiviral agents remains a priority to combat viral infections.
Purpose of the Study:
- To synthesize and characterize novel acyclic nucleoside and acyclic nucleoside phosphonate analogues incorporating an imidazole ring.
- To evaluate the in vitro antiviral activity of these synthesized compounds against a range of herpes and respiratory viruses.
- To identify potent antiviral agents, particularly against measles virus.
Main Methods:
- Synthesis of various imidazole-containing acyclic nucleoside and phosphonate analogues.
- Preparation of prodrugs and protected precursors for selected compounds.
- In vitro screening of synthesized compounds against a panel of herpes and respiratory viruses.
- Determination of antiviral activity, including EC50 and selectivity index (SI) values.
Main Results:
- Several acyclic nucleoside and phosphonate analogues with imidazole cores were successfully synthesized.
- Compound 9, a phosphonate analogue, exhibited potent in vitro activity against measles virus.
- Compound 9 demonstrated a low EC50 value (<2.5 microg/mL) and a high SI value (>176) against measles virus.
Conclusions:
- The synthesized imidazole-containing acyclic nucleoside phosphonate analogues represent a promising class of antiviral compounds.
- The phosphonate analogue 9 is a particularly strong candidate for further development as an anti-measles virus therapeutic.
- Further research into these analogues could lead to new treatments for viral diseases.